Abstract:We have previously found, in striatal membrane preparations from young (2 months old) rats, that stimulation of adenosine A2 receptors (with the selective adenosine A2 agonist CGS 21680) increases the dissociation constants of high- (Kh) and low-affinity (Kl) dopamine D2 binding sites (labelled with the selective dopamine D2 antagonist [3H]raclopride) without changing the proportion of high affinity binding sites (Rh). In the present study in striatal preparations from adult (6 months old) rats, it was found that in addition to the increase in both Kh and Kl values, stimulation of adenosine A2 receptors is associated with an increase in Rh. These result suggest that, in the adult rat, adenosine A2 stimulation may inhibit the behavioural effects induced by dopamine D2 stimulation both by decreasing the affinity and the transduction of dopamine D2 receptors. We have also studied the intramembrane A2-D2 receptor interaction in an experimental model of Parkinson's disease, namely in rats with a unilateral 6-OH-dopamine-induced lesion of the nigro-striatal dopamine pathway. It was found that a unilateral dopamine denervation is associated with a higher density of striatal dopamine D2 receptors in the order of 20%, without any change in their affinity compared with the unlesioned neostriatum. Furthermore, the density (Bmax values) of dopamine D2 receptors in the contralateral neostriatum was significantly higher (about 20%) than in the striatum from native animals. This finding suggests that an unilateral dopamine denervation also induces compensatory long-lasting changes of dopamine D2 receptors in the contralateral neostriatum. In addition to the hightened sensitivity to dopamine agonists, it is known that the dopamine denervated striatum is more sensitive to adenosine antagonists like methylxanthines. If the adenosine A2-dopamine D2 interaction is the main mechanism of action mediating the central effects of methylxanthines, the dopamine denervation might also potentiate this interaction, i.e., dopamine D2 receptors could be not only more sensitive to dopamine but also to adenosine A2 receptor activation. Our results support this hypothesis, since membrane preparations from the denervated neostriatum are more sensitive to the effect of CGS 21680 on dopamine D2 receptors. Thus a low dose of CGS 21680 (3 nM), which is not effective in membrane preparations from the neostriatum of naive animals, is still effective in membranes from the denervated neostriatum. These results underline the potential antiparkinsonian activity of adenosine A2 antagonists.

D2 Dopamine Receptor Antisense Oligodeoxynucleotide Inhibits the Synthesis of a Functional Pool of D2 Dopamine Receptors.

In Vivo Administration of an Oligodeoxynucleotide Antisense to the D2 Dopamine Receptor Messenger RNA Inhibits D2 Dopamine Receptor-Mediated Behavior and the Expression of D2 Dopamine Receptors in Mouse Striatum.

Antisense Oligodeoxynucleotide Inhibits D2 Dopamine Receptor-Mediated Behavior and D2 Messenger RNA

D-2 Dopamine-Receptor Messenger-Rna Is Altered To A Greater Extent By Blockade Of Glutamate Receptors Than By Blockade Of Dopamine-Receptors

Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases D2 dopamine receptor mRNA and proenkephalin mRNA and decreases D1 dopamine receptor mRNA and mu and delta opioid receptors in rat striatum

Dopamine-Receptor Blockade Increases Dopamine D-2 Receptor And Glutamic-Acid Decarboxylase Messenger-Rnas In Mouse Substantia-Nigra

Dopamine receptor blockade increases dopamine D2 receptor and glutamic acid decarboxylase mRNAs in mouse substantia nigra.

The D2 Dopamine Receptor Interferes with the Protective Effect of the A(2A) Adenosine Receptor on TDP-43 Mislocalization in Experimental Models of Motor Neuron Degeneration

Dopamine D1 Receptors Contribute Critically to the Apomorphine-Induced Inhibition of Form-Deprivation Myopia in Mice.

Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder

A Peptide Targeting an Interaction Interface Disrupts the Dopamine D1‐D2 Receptor Heteromer to Block Signaling and Function in Vitro and in Vivo: Effective Selective Antagonism

Lesions Of Mouse Striatum Induced By 6-Hydroxydopamine Differentially Alter The Density, Rate Of Synthesis, And Level Of Gene-Expression Of D-1 And D-2 Dopamine-Receptors

Ablation of Gene Expression of N-methyl-D-aspartate Receptor One by Antisense Oligonucleotides in Striatal Neurons in Culture.

L-DOPA Treatment Modulates Nicotinic Receptors in Monkey Striatum.

Inhibition of Α‐synuclein Fibrillization by Dopamine Analogs Via Reaction with the Amino Groups of Α‐synuclein

Serotonergic Modulation of Nigrostriatal and Mesolimbic Dopamine and Motor/Exploratory Behaviors in the Rat

[Effects of Antisense Oligodeoxynucleotides Targeting Multidrug Resistance Gene on Resistant Cell Line K562/ AO2].

Dopamine Denervation Leads to an Increase in the Intramembrane Interaction Between Adenosine A2 and Dopamine D2 Receptors in the Neostriatum

Opposite regulation by L-DOPA receptor GPR143 of the long and short forms of the dopamine D2 receptors

The D3 receptor antagonist SR 21502 reduces cue-induced reinstatement of methamphetamine-seeking in rats

Dopamine D2L Receptor Deficiency Alters Neuronal Excitability and Spine Formation in Mouse Striatum